Trichostatin A Protects Liver against Septic Injury through Inhibiting Toll-Like Receptor Signaling |
Kim, So-Jin
(School of Pharmacy, Sungkyunkwan University)
Park, Jin-Sook (School of Pharmacy, Sungkyunkwan University) Lee, Do-Won (School of Pharmacy, Sungkyunkwan University) Lee, Sun-Mee (School of Pharmacy, Sungkyunkwan University) |
1 | Abraham, E. (2003) Nuclear factor- and its role in sepsis-associated organ failure. J. Infect. Dis. 187 Suppl 2, S364-S369. DOI |
2 | Baldwin, A. S. Jr. (1996) The NF- and proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683. DOI |
3 | Beg, A. A., Finco, T. S., Nantermet, P. V. and Baldwin, A. S. Jr. (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of : a mechanism for NF- activation. Mol. Cell. Biol. 13, 3301-3310. DOI |
4 | Bergt, S., Wagner, N. M., Heidrich, M., Butschkau, A., Noldge-Schomburg, G. E., Vollmar, B. and Roesner, J. P. (2013) Hydrocortisone reduces the beneficial effects of toll-like receptor 2 deficiency on survival in a mouse model of polymicrobial sepsis. Shock 40, 414-419. DOI |
5 | Bone, R. C. (1991) The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469. DOI |
6 | Chakravortty, D., Koide, N., Kato, Y., Sugiyama, T., Mu, M. M., Yoshida, T. and Yokochi, T. (2000) The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J. Endotoxin Res. 6, 243-247. DOI |
7 | Chaudry, I. H., Wichterman, K. A. and Baue, A. E. (1979) Effect of sepsis on tissue adenine nucleotide levels. Surgery 85, 205-211. |
8 | Chen, L. F., Mu, Y. and Greene, W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-. EMBOJ. 21, 6539-6548. DOI |
9 | Chen, Y. R., Wang, X., Templeton, D., Davis, R. J. and Tan, T. H. (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and radiation. J. Biol. Chem. 271, 31929-31936. DOI |
10 | Choi, J. H., Oh, S. W., Kang, M. S., Kwon, H. J., Oh, G. T. and Kim, D. Y. (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35, 89-96. DOI |
11 | Johnstone, R. W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1, 287-299. DOI |
12 | Ehrentraut, S., Lohner, R., Schwederski, M., Ehrentraut, H., Boehm, O., Noga, S., Langhoff, P., Baumgarten, G., Meyer, R. and Knuefermann, P. (2011) In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia. Shock 36, 613-620. DOI |
13 | Finkelstein, R. A., Li, Y., Liu, B., Shuja, F., Fukudome, E., Velmahos, G. C., deMoya M. and Alam, H. B. (2010) Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock. J. Surg. Res. 163, 146-154. DOI |
14 | Hebert, P. C., Drummond, A. J., Singer, J., Bernard, G. R. and Russell, J. A. (1993) A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104, 230-235. DOI |
15 | Kawai, T., Adachi, O., Ogawa, T., Takeda, K. and Akira, S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122. DOI |
16 | Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y., Kim, C. W. and Kim, K. W. (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7, 437-443. DOI |
17 | Lagu, T., Rothberg, M. B., Shieh, M. S., Pekow, P. S., Steingrub, J. S. and Lindenauer, P. K. (2012) Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit. Care Med. 40, 754-761. DOI |
18 | Li, Y. and Alam, H. B. (2011) Modulation of acetylation: creating a prosurvival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock. J. Biomed. Biotechnol. 2011, 523481. |
19 | Mittal, R., Peak-Chew, S. Y. and McMahon, H. T. (2006) Acetylation of MEK2 and kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 18574-18579. DOI |
20 | Luhrs, H., Gerke, T., Schauber, J., Dusel, G., Melcher, R., Scheppach, W. and Menzel, T. (2001) Cytokine-activated degradation of inhibitory protein a is inhibited by the short-chain fatty acid butyrate. Int. J. Colorectal Dis. 16, 195-201. DOI |
21 | Nasu, Y., Nishida, K., Miyazawa, S., Komiyama, T., Kadota, Y., Abe, N., Yoshida, A., Hirohata, S., Ohtsuka, A. and Ozaki, T. (2008) Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthr. Cartil. 16, 723-732. DOI |
22 | Nesseler, N., Launey, Y., Aninat, C., Morel, F., Malledant, Y. and Seguin, P. (2012) Clinical review: The liver in sepsis. Crit. Care 16, 235. DOI |
23 | Pan, L. N., Lu, J. and Huang, B. (2007) HDAC inhibitors: a potential new category of anti-tumor agents. Cell. Mol. Immunol. 4, 337-343. |
24 | Riedemann, N. C., Guo, R. F. and Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524. DOI |
25 | Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A. L., Reymond, M. K., Miconnet, I., Schrenzel, J., Francois, P. and Calandra, T. (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117, 1205-1217. DOI |
26 | Sha, T., Iizawa, Y. and Ii, M. (2011) Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis. Shock 35, 205-209. DOI |
27 | Tong, X., Yin, L. and Giardina, C. (2004) Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem. Biophys. Res. Commun. 317, 463-471. DOI |
28 | Singhal, S., Alulen, M. W., McAnnally, J. R., Smith, K. S., Donnelly, J. P. and Wang, H. E. (2013) National estimates of emergency department visits for pediatric severe sepsis in the United States. PeerJ 1, e79. DOI |
29 | Takala, A., Nupponen, I., Kylanpaa-Back, M. L. and Repo, H. (2002) Markers of inflammation in sepsis. Ann. Med. 34, 614-623. DOI |
30 | Takashima, K., Matsunaga, N., Yoshimatsu, M., Hazeki, K., Kaisho, T., Uekata, M., Hazeki, O., Akira, S., Iizawa, Y. and Ii M. (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157, 1250-1262. DOI |
31 | Toscano, M. G., Ganea, D. and Gamero, A. M. (2011) Cecal ligation puncture procedure. J. Vis. Exp. 2860. |
32 | Williams, D. L., Ha, T., Li, C., Kalbfleisch, J. H., Schweitzer, J., Vogt, W. and Browder, I. W. (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31, 1808-1818. DOI |
33 | Wu, J. and Grunstein, M. (2000) 25 years after the nucleosome model:chromatin modifications. Trends Biochem. Sci. 25, 619-623. DOI |
34 | Zhang, L., Jin, S., Wang, C., Jiang, R. and Wan, J. (2010) Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World J. Surg. 34, 1676-1683. DOI |
35 | Zhao, T., Li, Y., Liu, B., Liu, Z., Chong, W., Duan, X., Deperalta, D. K., Velmahos, G. C. and Alam, H. B. (2013) Novel pharmacologic treatment attenuates septic shock and improves long-term survival. Surgery 154, 206-213. DOI |
36 | Zhang, L., Wan, J., Jiang, R., Wang, W., Deng, H., Shen, Y., Zheng, W. and Wang, Y. (2009) Protective effects of trichostatin A on liver injury in septic mice. Hepatol. Res. 39, 931-938. DOI |